Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
RAFFLESINTERIOR(01376): Chen Minghui appointed as chairman.
MEGA GENOMICS (06667) spent HKD 116,000 to repurchase 18,800 shares on June 17.
Contemporary Amperex Technology (03750): In 2026, the company will publicly issue technology innovation corporate bonds (second tranche) to professional investors with a coupon rate of 1.49%.
RAFFLESINTERIOR(01376): Chen Minghui appointed as chairman.
MEGA GENOMICS (06667) spent HKD 116,000 to repurchase 18,800 shares on June 17.
Contemporary Amperex Technology (03750): In 2026, the company will publicly issue technology innovation corporate bonds (second tranche) to professional investors with a coupon rate of 1.49%.
RECOMMEND
